{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:36:33Z","timestamp":1785458193187,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatoid adenocarcinoma (HAC) is rare in the urinary system, with only 7 reported cases in upper urinary tract. This report aimed to explore the genetic characteristics of ureteral HAC for first time, and to describe the treatment prognosis of ureteral HAC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present a rare case of ureteral HAC in a 53-year-old female, showing elevated serum levels of AFP and CEA, prolonged chronic irritation may be an important cause of her ureteral HAC. Radical nephroureterectomy was performed, the serum levels of AFP and CEA decreased significantly, and metastasis in lymph nodes was found at 9\u2009months after surgery, she had no related symptoms after 18\u2009months postoperatively without adjuvant chemotherapy. Three driver somatic mutations in cancer were identified by NGS testing, including: TP53<jats:sup>D281H<\/jats:sup>, KMT2D<jats:sup>L1211Ifs*2<\/jats:sup>, KMT2D<jats:sup>T1843Nfs*5<\/jats:sup>, demonstrating that ureteral HAC has the similar mutational features to upper tract urothelial carcinoma. Homologous-recombination deficiency (HRD) was positive in this tumor with no mutations in HRD-related genes, which was possibly induced by the copy number deletion of SETD2 gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We report a rare case of ureteral HAC with elevated serum levels of AFP and CEA. NGS testing demonstrated that ureteral HAC has the similar mutational features to upper tract urothelial carcinoma, which is an important guide for the diagnosis and treatment of ureteral HAC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01776-5","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:07:14Z","timestamp":1704208034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatoid adenocarcinoma in ureter with next-generation sequencing: A case report and literature review"],"prefix":"10.1186","volume":"17","author":[{"given":"Mengxin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"3","key":"1776_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3748\/wjg.v19.i3.321","volume":"19","author":"JS Su","year":"2013","unstructured":"Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol. 2013;19(3):321\u20137.","journal-title":"World J Gastroenterol."},{"issue":"4","key":"1776_CR2","first-page":"840","volume":"56","author":"H Ishikura","year":"1985","unstructured":"Ishikura H, Fukasawa Y, Ogasawara K, Natori T, Tsukada Y, Aizawa M. An AFP-producing gastric carcinoma with features of hepatic differentiation. A case report Cancer. 1985;56(4):840\u20138.","journal-title":"A case report Cancer."},{"issue":"4","key":"1776_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00428-003-0772-8","volume":"442","author":"A Lopez-Beltran","year":"2003","unstructured":"Lopez-Beltran A, Luque RJ, Quintero A, Requena MJ, Montironi R. Hepatoid adenocarcinoma of the urinary bladder. Virchows Arch. 2003;442(4):381\u20137.","journal-title":"Virchows Arch."},{"key":"1776_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1752-1947-7-12","volume":"7","author":"Y Sekino","year":"2013","unstructured":"Sekino Y, Mochizuki H, Kuniyasu H. A 49-year-old woman presenting with hepatoid adenocarcinoma of the urinary bladder: a case report. J Med Case Rep. 2013;7:12.","journal-title":"J Med Case Rep."},{"issue":"2","key":"1776_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.21873\/anticanres.11380","volume":"37","author":"P Friedman","year":"2017","unstructured":"Friedman P, Lai JP. Liver metastasis of urothelial carcinoma with Hepatoid features: an unusual morphological finding. Anticancer Res. 2017;37(2):801\u20134.","journal-title":"Anticancer Res."},{"issue":"5","key":"1776_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.currproblcancer.2018.12.007","volume":"43","author":"J Huang","year":"2019","unstructured":"Huang J, Zhu R, Wu R, Li R, Yao N, Deng S. Hepatoid adenocarcinoma of the renal pelvis in a 59-year-old male with nephrolithiasis: case report and review of the literature. Curr Probl Cancer. 2019;43(5):471\u20136.","journal-title":"Curr Probl Cancer."},{"issue":"4","key":"1776_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/PAS.0b013e3181d1dcdd","volume":"34","author":"T Ushiku","year":"2010","unstructured":"Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N, et al. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol. 2010;34(4):533\u201340.","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"1776_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eururo.2017.05.048","volume":"72","author":"TJ Moss","year":"2017","unstructured":"Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, et al. Comprehensive genomic characterization of upper tract urothelial carcinoma. Eur Urol. 2017;72(4):641\u20139.","journal-title":"Eur Urol."},{"issue":"25","key":"1776_CR9","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa1911361","volume":"381","author":"I Ray-Coquard","year":"2019","unstructured":"Ray-Coquard I, Pautier P, Pignata S, P\u00e9rol D, Gonz\u00e1lez-Mart\u00edn A, Berger R, et al. Olaparib plus bevacizumab as first-line maintenance in ovarian Cancer. N Engl J Med. 2019;381(25):2416\u201328.","journal-title":"N Engl J Med."},{"issue":"6230","key":"1776_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348(6230):124\u20138.","journal-title":"Science."},{"issue":"11","key":"1776_CR11","first-page":"1156","volume":"117","author":"SE Spires","year":"1993","unstructured":"Spires SE, Banks ER, Cibull ML, Munch L, Delworth M, Alexander NJ. Adenocarcinoma of renal pelvis. Arch Pathol Lab Med. 1993;117(11):1156\u201360.","journal-title":"Arch Pathol Lab Med."},{"issue":"3","key":"1776_CR12","first-page":"589","volume":"33","author":"S Kobayashi","year":"1983","unstructured":"Kobayashi S, Ohmori M, Akaeda T, Ohmori H, Miyaji Y. Primary adenocarcinoma of the renal pelvis. Report of two cases and brief review of literature. Acta Pathol Jpn. 1983;33(3):589\u201397.","journal-title":"Acta Pathol Jpn."},{"issue":"1","key":"1776_CR13","first-page":"45","volume":"51","author":"P Kalafatis","year":"1999","unstructured":"Kalafatis P, Zarifis I, Sotrillis T, Stefis A. Mucinous adenocarcinoma of the renal pelvis associated with renal calculi of the inflammatory type. Minerva Urol Nefrol. 1999;51(1):45\u20138.","journal-title":"Minerva Urol Nefrol."},{"issue":"2","key":"1776_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1442-2042.2004.00745.x","volume":"11","author":"Y Shiga","year":"2004","unstructured":"Shiga Y, Kawai K, Shimazui T, Iijima T, Noguchi M, Akaza H. Case of alpha-fetoprotein-producing transitional cell carcinoma of the renal pelvis. Int J Urol. 2004;11(2):117\u20138.","journal-title":"Int J Urol."},{"issue":"12","key":"1776_CR15","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1002\/1097-0142(19910615)67:12<3051::AID-CNCR2820671220>3.0.CO;2-C","volume":"67","author":"H Ishikura","year":"1991","unstructured":"Ishikura H, Ishiguro T, Enatsu C, Fujii H, Kakuta Y, Kanda M, et al. Hepatoid adenocarcinoma of the renal pelvis producing alpha-fetoprotein of hepatic type and bile pigment. Cancer. 1991;67(12):3051\u20136.","journal-title":"Cancer."},{"issue":"2","key":"1776_CR16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000282339","volume":"48","author":"M Hosomi","year":"1992","unstructured":"Hosomi M, Sagawa S, Kotou Y. Alpha-fetoprotein-producing adenocarcinoma of the ureter. Urol Int. 1992;48(2):226\u20137.","journal-title":"Urol Int."},{"issue":"6","key":"1776_CR17","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/S0022-5347(05)64189-4","volume":"168","author":"Y Aida","year":"2002","unstructured":"Aida Y, Kudo O, Yamakawa K, Kato K, Tadokoro M, Takahashi T. Papillary adenocarcinoma of the ureter producing carcinoembryonic antigen and carbohydrate antigen 19-9. J Urol. 2002;168(6):2535\u20136.","journal-title":"J Urol."},{"issue":"5","key":"1776_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/PAI.0b013e318216af63","volume":"19","author":"M Rotellini","year":"2011","unstructured":"Rotellini M, Messerini L, Stomaci N, Raspollini MR. Hepatoid adenocarcinoma of the ureter: unusual case presenting hepatic and ovarian metastases. Appl Immunohistochem Mol Morphol. 2011;19(5):478\u201383.","journal-title":"Appl Immunohistochem Mol Morphol."},{"issue":"11","key":"1776_CR19","first-page":"4987","volume":"32","author":"H Samaratunga","year":"2012","unstructured":"Samaratunga H, Samaratunga D, Dunglison N, Perry-Keene J, Nicklin J, Delahunt B. Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation. Anticancer Res. 2012;32(11):4987\u201391.","journal-title":"Anticancer Res."},{"issue":"12","key":"1776_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/jmedgenet-2018-105565","volume":"55","author":"JS Lee","year":"2018","unstructured":"Lee JS, Oh S, Park SK, Lee MH, Lee JW, Kim SW, et al. Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort. J Med Genet. 2018;55(12):794\u2013802.","journal-title":"J Med Genet."},{"issue":"38","key":"1776_CR21","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1038\/s41388-021-01976-2","volume":"40","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang A, Pu Y, Li Z, Xue R, Zhang C, et al. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach. Oncogene. 2021;40(38):5705\u201317.","journal-title":"Oncogene."},{"issue":"1","key":"1776_CR22","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1038\/s41467-020-19406-4","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen L, WM Martens J, Van Hoeck A, Cuppen E. Pan-cancer landscape of homologous recombination deficiency. Nat Commun. 2020;11(1):5584.","journal-title":"Nat Commun."},{"key":"1776_CR23","doi-asserted-by":"publisher","first-page":"e02482","DOI":"10.7554\/eLife.02482","volume":"3","author":"S Carvalho","year":"2014","unstructured":"Carvalho S, V\u00edtor AC, Sridhara SC, Martins FB, Raposo AC, Desterro JM, et al. SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. Elife. 2014;3:e02482.","journal-title":"Elife."},{"issue":"4","key":"1776_CR24","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen T, Chen X, Zhang S, Zhu J, Tang B, Wang A, et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom Proteom Bioinform. 2021;19(4):578\u201383.","journal-title":"Genom Proteom Bioinform."},{"issue":"D1","key":"1776_CR25","doi-asserted-by":"publisher","first-page":"D27","DOI":"10.1093\/nar\/gkab951","volume":"50","author":"CNCB-NGDC Members and Partners","year":"2022","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for bioinformation in 2022. Nucleic Acids Res. 2022;50(D1):D27\u201338.","journal-title":"Nucleic Acids Res."}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01776-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01776-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:10:30Z","timestamp":1704208230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01776-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1776"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01776-5","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Medical Ethics Committee, Zhongnan Hospital of Wuhan University (Ethical Approval No. 2020102). The patient provided her written informed consent to participate in this study. The study was carried out in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participation"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}